|
It is estimated that around 185,000 individuals in the UK
are chronically infected with the hepatitis C virus (HCV)
(Health Protection Agency, 2009).
The prevalence among intravenous drug users
varies between 53% and 96%. In patients enrolled in methadone
maintenance programmes, it has a prevalence of between 67% and
96% (Novick, 2008).
The high rate of co-occurring substance misuse
disorders and severe mental illness coupled with HCV infection
requires psychiatrists to be aware of the important and complex
issues involved in their management.
The aim of this module is to explore the
relationship between hepatitis C and mental health and to offer
guidance on management. This is particularly applicable to
substance misuse and liaison psychiatrists as they deal with the
complex areas of hepatitis C, substance misuse and the effects
on physical and mental health.
Start the
module
|
Download take-home notes to
print and annotate
|